Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in

Daisuke Suzuki1, Masao Toyoda, Naoyuki Yamamoto

  • 1Division of Nephrology and Metabolism, Department of Internal Medicine, School of Medicine, Tokai University, Isehara.

Abstract

Insights

Advanced glycation end-products (AGE) and the receptor for advanced glycation end-products (RAGE) are linked to kidney damage in diabetic nephropathy. Increased AGE and RAGE expression correlates with mesangial expansion in DN.

Area of Science:

  • Nephrology
  • Diabetology
  • Molecular Biology

Background:

  • The receptor for advanced glycation end-products (RAGE) is a cellular receptor for advanced glycation end-products (AGEs).
  • Diabetic nephropathy (DN) is a serious complication of diabetes characterized by kidney damage.
  • The roles of AGEs and RAGE in the pathogenesis of DN require further elucidation.

Purpose of the Study:

  • To investigate the relationship between AGE protein and RAGE mRNA expression in renal tissues of patients with diabetic nephropathy (DN).
  • To examine the correlation between AGE and RAGE expression and the degree of mesangial expansion in DN.

Main Methods:

  • Renal biopsy tissues from 20 DN patients and 5 controls were analyzed.
  • Immunohistochemistry for AGE protein and in situ hybridization for RAGE mRNA were performed.
  • Glomerular mesangial expansion (%Mes) was quantified using an image analyzer.

Main Results:

  • AGE protein was detected in the mesangial matrix of DN kidneys but not in controls.
  • RAGE mRNA was expressed in glomerular cells in both DN and control samples.
  • %Mes significantly correlated with both AGE protein staining intensity and RAGE mRNA expression.

Conclusions:

  • Both AGEs and RAGE are associated with the development and progression of diabetic nephropathy.
  • These findings highlight the potential involvement of the AGE-RAGE pathway in DN pathogenesis.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...